Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT05133193
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18-70 years were recruited for this study if they had failed at least three rounds of anti- H. pylori therapies.
Exclusion Criteria:
* Patients treated with H2-receptor antagonist, PPI, vonoprazan, bismuth and antibiotics in the previous 4 weeks
* Patients with gastorectomy, acute GI bleeding and advanced gastric cancer,
* History of allergy to any of the drugs used in the study,
* Severe concomitant cardiovascular, respiratory, or endocrine diseases, clinically significant renal or hepatic disease, hematologic disorders and any other clinically significant medical condition that could increase risk,
* Currently pregnant or lactating,
* Severe neurologic or psychiatric disorders,
* Alcohol abuse or drug addiction,
* Patients with compliance lower than 90% in any previous treatment,
* Inability to provide informed consent and other situations that could interfere with the examination or therapeutic protocol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05133193
Study Brief:
Protocol Section:
NCT05133193